Skip to main navigation
Caribou Biosciences, Inc. Logo

Presentations

Corporate presentations

Caribou Corporate Presentation April 2026

Data presentations

Clinical and translational data for CB-011 CaMMouflage Phase 1 clinical trial, Tandem Meetings 2026 presentation
Translational data for vispa-cel ANTLER Phase 1 clinical trial, Tandem Meetings 2026 poster
Clinical updates for vispa-cel (CB-010) and first clinical data for CB-011, company event 2025
CB-010 LBCL clinical data and KOL discussion, ASCO 2024 presentation
CB-010 LBCL clinical data, ASCO 2024 poster
CB-010 LBCL clinical case study, iwCAR-T presentation
CB-010 LBCL clinical case study, LLM 2023 poster
CB-010 B-NHL clinical data, July 2023 presentation
CB-011 MM preclinical data, ASCO 2023 trials-in-progress poster
CB-011 MM preclinical data, Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® 2023 poster
Pagination
  • Current page 1
  • Page 2
  • Next page ›
  • Last page »

Print page

Email alerts

RSS feeds

Investor contact

  • News & events
    • Press releases
    • Events
    • Presentations
  • Stock information
    • Stock quote & chart
    • Analyst coverage
  • Corporate governance
    • Policies & charters
    • Leadership
    • Board of Directors
    • Committee composition
  • Financials & filings
    • SEC filings
  • IR resources
    • FAQs
    • Email alerts
    • Contact IR
  • More
    • About
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Partnering
    • Technology
      • chRDNA technology
      • CAR-T cell therapy platform
      • Scientific publications
    • Pipeline
      • T cell pipeline
      • Clinical trials
      • Videos
    • Careers
      • Job opportunities
      • Values
      • Diversity and inclusion
      • Benefits
    • Investors
      • News & events
        • Press releases
        • Events
        • Presentations
      • Stock information
        • Stock quote & chart
        • Analyst coverage
      • Corporate governance
        • Policies & charters
        • Leadership
        • Board of Directors
        • Committee composition
      • Financials & filings
        • SEC filings
      • IR resources
        • FAQs
        • Email alerts
        • Contact IR
    • Contact
    • About
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Partnering
    • Technology
      • chRDNA technology
      • CAR-T cell therapy platform
      • Scientific publications
    • Pipeline
      • T cell pipeline
      • Clinical trials
      • Videos
    • Careers
      • Job opportunities
      • Values
      • Diversity and inclusion
      • Benefits
    • Investors
      • News & events
        • Press releases
        • Events
        • Presentations
      • Stock information
        • Stock quote & chart
        • Analyst coverage
      • Corporate governance
        • Policies & charters
        • Leadership
        • Board of Directors
        • Committee composition
      • Financials & filings
        • SEC filings
      • IR resources
        • FAQs
        • Email alerts
        • Contact IR
    • Contact

    Caribou Biosciences, Inc. Logo

    Caribou Biosciences, Inc.
    2929 7th Street, Suite 105
    Berkeley, CA 94710
    Tel: 510-982-6030

    © 2026 Caribou Biosciences, Inc. All rights reserved.
    • Privacy policy
    • Terms of use
    • Twitter
    • linkedin
    Website Design: Hane Chow, Inc .